SCHEMBL7531332

SCHEMBL7531332

[c]1ccc(-c2csc(NC3CCNCC3)n2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
BAZ2A Q9UIF9 1/20 0.45
NPY5R Q15761 1/20 0.42
TYR P14679 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ITGB3 P05106 4/20 0.40
ITGA2B P08514 4/20 0.40
IKBKB O14920 1/20 0.40
CXCR3 P49682 1/20 0.38
ENPP2 Q13822 1/20 0.38
LMNA P02545 2/20 0.38
MAOA P21397 3/20 0.37
MAOB P27338 3/20 0.37
MAPT P10636 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8118408 0.84 KDM4E (0.59) NPC1RAB9AKDM4EMAOAMAOB
Hydrochloric Acid SCHEMBL8824042 0.83 KDM4E (0.58) NPC1RAB9AKDM4EMAOAMAOB
SCHEMBL27575993 0.80 ITGB3 (0.54) NPC1RAB9ABAZ2AKDM4EITGB3
SCHEMBL7430139 0.79 ITGB3 (0.56) NPC1RAB9ABAZ2ANPY5RKDM4E
Bromide SCHEMBL6185442 0.79 ITGB3 (0.53) NPC1RAB9ABAZ2AKDM4EITGB3
SCHEMBL14349548 0.77 RAB9A (0.54) NPC1RAB9ABAZ2ATYRKDM4E
SCHEMBL4155889 0.75 NPC1 (0.52) NPC1RAB9ABAZ2ANPY5RTYR
SCHEMBL25140729 0.74 KCNH2 (0.52) NPC1RAB9ANPY5RKDM4EMEN1
SCHEMBL7533964 0.73 ENPP2 (0.51) NPC1RAB9AITGB3ITGA2BENPP2
SCHEMBL13334977 0.72 BAZ2A (0.43) NPC1RAB9ABAZ2ANPY5RTYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002023784-A2 CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-03-21 WO claimed
WO-2002023784-A2 CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-03-21 WO disclosed